Low circulating choline, a modifiable dietary factor, is associated with the pathological progression and metabolome dysfunction in Alzheimer’s disease
暂无分享,去创建一个
J. Klein-Seetharaman | T. Beach | G. Serrano | R. Velazquez | W. Winslow | P. Jasbi | Jessica M Judd
[1] M. A. Siddik,et al. Branched-Chain Amino Acids Are Linked with Alzheimer’s Disease-Related Pathology and Cognitive Deficits , 2022, Cells.
[2] Corrie M. Whisner,et al. Exploratory analysis of one versus two-day intermittent fasting protocols on the gut microbiome and plasma metabolome in adults with overweight/obesity , 2022, Frontiers in Nutrition.
[3] J. Doecke,et al. Multi-Omics, an Integrated Approach to Identify Novel Blood Biomarkers of Alzheimer’s Disease , 2022, Metabolites.
[4] Corrie M. Whisner,et al. Association of food insecurity on gut microbiome and metabolome profiles in a diverse college-based sample , 2022, Scientific Reports.
[5] R. Velazquez,et al. Dietary choline intake is necessary to prevent systems‐wide organ pathology and reduce Alzheimer's disease hallmarks , 2022, bioRxiv.
[6] R. Au,et al. Is dietary choline intake related to dementia and Alzheimer's disease risks? Results from the Framingham Heart Study , 2022, The American journal of clinical nutrition.
[7] M. Huentelman,et al. Glyphosate infiltrates the brain and increases pro-inflammatory cytokine TNFα: implications for neurodegenerative disorders , 2022, Journal of Neuroinflammation.
[8] R. Unwin,et al. Coenzyme A-Dependent Tricarboxylic Acid Cycle Enzymes Are Decreased in Alzheimer’s Disease Consistent With Cerebral Pantothenate Deficiency , 2022, Frontiers in Aging Neuroscience.
[9] H. Pérez‐Sánchez,et al. Hydroxybenzoic Acids as Acetylcholinesterase Inhibitors: Calorimetric and Docking Simulation Studies , 2022, Nutrients.
[10] Anonymous,et al. 2022 Alzheimer's disease facts and figures , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.
[11] Corrie M. Whisner,et al. Microbiome and metabolome profiles of high screen time in a cohort of healthy college students , 2022, Scientific Reports.
[12] Tao Yang,et al. High L-Valine Concentrations Associate with Increased Oxidative Stress and Newly-Diagnosed Type 2 Diabetes Mellitus: A Cross-Sectional Study , 2022, Diabetes, metabolic syndrome and obesity : targets and therapy.
[13] Liying Zhuang,et al. Choline Intake Correlates with Cognitive Performance among Elder Adults in the United States , 2021, Behavioural neurology.
[14] Yulan Wang,et al. Understanding Choline Bioavailability and Utilization: First Step Toward Personalizing Choline Nutrition. , 2021, Journal of agricultural and food chemistry.
[15] Ian M. McDonough,et al. IntelliCage Automated Behavioral Phenotyping Reveals Behavior Deficits in the 3xTg-AD Mouse Model of Alzheimer’s Disease Associated With Brain Weight , 2021, Frontiers in Aging Neuroscience.
[16] T. Beach,et al. Metabolic Profiling of Neocortical Tissue Discriminates Alzheimer's Disease from Mild Cognitive Impairment, High Pathology Controls, and Normal Controls. , 2021, Journal of proteome research.
[17] M. Khambete,et al. Therapeutic potential of ferulic acid and its derivatives in Alzheimer’s disease—A systematic review , 2021, Chemical biology & drug design.
[18] M. Verbeek,et al. Prevalence of cerebral amyloid angiopathy: A systematic review and meta‐analysis , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.
[19] M. Huentelman,et al. Identification of retinoblastoma binding protein 7 (Rbbp7) as a mediator against tau acetylation and subsequent neuronal loss in Alzheimer’s disease and related tauopathies , 2021, Acta Neuropathologica.
[20] R. Velazquez,et al. Sex differences in the IntelliCage and the Morris water maze in the APP/PS1 mouse model of amyloidosis , 2021, Neurobiology of Aging.
[21] K. Blennow,et al. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts , 2020, The Lancet Neurology.
[22] Rui Zhang,et al. Discovery and Comparison of Serum Biomarkers for Diabetes Mellitus and Metabolic Syndrome Based on UPLC-Q-TOF/MS. , 2020, Clinical biochemistry.
[23] B. Polis,et al. Role of the metabolism of branched-chain amino acids in the development of Alzheimer's disease and other metabolic disorders , 2020, Neural regeneration research.
[24] R. Killiany,et al. Association of White Matter Rarefaction, Arteriolosclerosis, and Tau With Dementia in Chronic Traumatic Encephalopathy. , 2019, JAMA neurology.
[25] M. Roberson,et al. Maternal choline supplementation alters vitamin B-12 status in human and murine pregnancy. , 2019, The Journal of nutritional biochemistry.
[26] S. Oddo,et al. Lifelong choline supplementation ameliorates Alzheimer’s disease pathology and associated cognitive deficits by attenuating microglia activation , 2019, Aging cell.
[27] Xuedan Chen,et al. Choline Supplementation Ameliorates Behavioural Deficits and Alzheimer's Disease-Like Pathology in Transgenic APP/PS1 Mice. , 2019, Molecular nutrition & food research.
[28] D. Dickson,et al. The neuropathological diagnosis of Alzheimer’s disease , 2019, Molecular Neurodegeneration.
[29] D. Hervás,et al. Plasma metabolomics in early Alzheimer's disease patients diagnosed with amyloid biomarker. , 2019, Journal of proteomics.
[30] A. Moser,et al. Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer’s Disease Mimic Accelerated Aging , 2018, Journal of Alzheimer's disease : JAD.
[31] Hui Zheng,et al. Practical considerations for choosing a mouse model of Alzheimer’s disease , 2017, Molecular Neurodegeneration.
[32] L. Denner,et al. Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease , 2017, Neurobiology of Aging.
[33] B. Vellas,et al. Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analyses , 2017, Alzheimer's & dementia.
[34] W. M. van der Flier,et al. Nutrients required for phospholipid synthesis are lower in blood and cerebrospinal fluid in mild cognitive impairment and Alzheimer's disease dementia , 2017, Alzheimer's & dementia.
[35] S. Zeisel. Choline, Other Methyl-Donors and Epigenetics , 2017, Nutrients.
[36] Debomoy K Lahiri,et al. Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease. , 2016, Current Alzheimer research.
[37] D. Ryglewicz,et al. Homocysteine metabolism and the associations of global DNA methylation with selected gene polymorphisms and nutritional factors in patients with dementia , 2016, Experimental Gerontology.
[38] V. Stallings,et al. Choline supplementation alters some amino acid concentrations with no change in homocysteine in children with cystic fibrosis and pancreatic insufficiency. , 2016, Nutrition research.
[39] T. H. Ferreira-Vieira,et al. Alzheimer's Disease: Targeting the Cholinergic System , 2016, Current neuropharmacology.
[40] S. Virtanen,et al. Dietary intake and food sources of choline in European populations. , 2015, The British journal of nutrition.
[41] D. Szwajgier. Anticholinesterase activity of selected phenolic acids and flavonoids - interaction testing in model solutions. , 2015, Annals of agricultural and environmental medicine : AAEM.
[42] H. Shill,et al. Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program , 2015, Neuropathology : official journal of the Japanese Society of Neuropathology.
[43] C. Barbas,et al. Metabolomic profiling of serum in the progression of Alzheimer's disease by capillary electrophoresis–mass spectrometry , 2014, Electrophoresis.
[44] E. Mufson,et al. Maternal choline supplementation improves spatial mapping and increases basal forebrain cholinergic neuron number and size in aged Ts65Dn mice , 2014, Neurobiology of Disease.
[45] G. Perry,et al. Phosphorylation of tau protein at sites Ser396–404 is one of the earliest events in Alzheimer's disease and Down syndrome , 2014, Neuropathology and applied neurobiology.
[46] E. Mufson,et al. Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome , 2013, Neurobiology of Disease.
[47] Zhenxin Zhang,et al. PEMT G523A (V175M) Is Associated with Sporadic Alzheimer's Disease in a Chinese Population , 2012, Journal of Molecular Neuroscience.
[48] Xianlin Han,et al. Metabolomics in Early Alzheimer's Disease: Identification of Altered Plasma Sphingolipidome Using Shotgun Lipidomics , 2011, PloS one.
[49] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[50] H. Keller,et al. Mealtime Experiences of Families With Dementia , 2007, American journal of Alzheimer's disease and other dementias.
[51] P. Lockman,et al. The Transport of Choline , 2002, Drug development and industrial pharmacy.
[52] H. Suh,et al. Protection against β‐amyloid peptide toxicity in vivo with long‐term administration of ferulic acid , 2001, British journal of pharmacology.
[53] W. Herrmann,et al. Role of homocysteine, cystathionine and methylmalonic acid measurement for diagnosis of vitamin deficiency in high‐aged subjects , 2000, European journal of clinical investigation.
[54] J. Klein. Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids , 2000, Journal of Neural Transmission.
[55] S. Zeisel,et al. Prolonged fasting in humans results in diminished plasma choline concentrations but does not cause liver dysfunction. , 1997, The American journal of clinical nutrition.
[56] John Q. Trojanowski,et al. Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease , 1997, Neurobiology of Aging.
[57] R. Cotter,et al. Mass Spectrometry , 1992, Bio/Technology.
[58] R. Wurtman,et al. “Autocannibalism” of choline-containing membrane phospholipids in the pathogenesis of Alzheimer's disease—A hypothesis , 1985, Neurochemistry International.
[59] R. Wurtman,et al. Choline production from choline-containing phospholipids: A hypothetical role in Alzheimer's disease and aging , 1984, Progress in Neuro-Psychopharmacology and Biological Psychiatry.